BACKGROUND Metastatic epithelioid hemangioendothelioma of the kidney is a rare malignant vascular tumor with a wide spectrum of behaviors .	[]
CASE REPORT We present the case of a 53-year-old male patient with tumor metastases which developed after radical nephrectomy .	[]
We describe the immunohistochemistry profile of the tumor and the successful long-term results of treatment with sunitinib , a multi-targeted tyrosine kinase inhibitor .	[]
Also , we discuss the rationale for using this type of medication based on immunohistochemistry results .	[]
CONCLUSION To the best of our knowledge , this is the first reported case of metastatic renal epithelioid hemangioendothelioma treated successfully with sunitinib .	['activating invasion and metastasis']
